| Literature DB >> 31249630 |
Abstract
BACKGROUND: Shigella has evolved as a result of acquiring extragenetic material through horizontal gene exchange. These aid in the rapid emergence of bacterial inter-strain diversity in virulence factors and serotype variants through O-antigenic switching. Plasmid incompatibility typing of isolates is insightful in understanding local expansion of virulence plasmids, as whether virulence dissemination involves diverse plasmids or one dominant 'epidemic' type. The broad question underlying this study was that of how inter-strain genetic, serotype and plasmid incompatibility type variations can help understand the emergence of Shigella as a highly virulent pathogen.Entities:
Keywords: O-antigen; Plasmid incompatibility typing; Serotype variation; Shigella flexneri; Virulence
Year: 2019 PMID: 31249630 PMCID: PMC6567616 DOI: 10.1186/s13099-019-0314-9
Source DB: PubMed Journal: Gut Pathog ISSN: 1757-4749 Impact factor: 4.181
Distribution and agglutination reactions of S. flexneri isolates in this study
| Antisera specific for all type- and group-factor antigens | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Typing sera | Grouping sera | |||||||||||
| Isolate | Serotype | B | I | II | III | IV | V | VI | 3 (4) | 6 | 7 (8) | |
|
| Type 2a | 48/101 | + | − | + | − | − | − | − | + | − | − |
| Type 6 | 15/101 | + | − | − | − | − | − | + | − | − | − | |
| Type 1b | 8/101 | + | + | − | − | − | − | − | − | + | − | |
| Type 1 variant* (1v) | 7/101 | + | + | − | − | − | − | − | − | − | − | |
| Type 3b | 12/101 | + | − | − | + | − | − | − | − | + | − | |
| Type 4 | 6/101 | + | − | − | − | + | − | − | − | − | − | |
| Variant X | 1/101 | + | − | − | − | − | − | − | − | − | + | |
| Variant Y | 2/101 | + | − | − | − | − | − | − | + | − | − | |
| Nontypable | 2/101 | + | − | − | − | − | − | − | − | − | − | |
*Identified in this study only
Frequency of the serotype distribution of S. flexneri subtypes
| National and International studies | |
|---|---|
| Present study, India (n = 101) | 2a > 6 > 3b > 1b > 1v > 4 |
| Kolkata, 2010, India (n = 154) | 2a > 3a |
| Kolkata, 2014, India (n = 47) | 2a > 3a > 6 > 4a > 7a/1c |
| Bay of Bengal Islands, India 2014 (n = 55) | 2a > 4a > 3b = X > 3a = 1a = 6 |
| China, 2013 (n = 4295) | 2a > 4c/Xv > X > 4a = 1a > 2b > Y > 6 > 4b > 5a = 3a > 1b |
| China, 2017 (n = 545) | 2a > 2b > 1a > 1b > X > 4c/Xv > Y > 6 > 4a > 3b |
| China, 2018 (n = 365) | 2a > 1b > 2b > 6 > X > 1a > Y > 4 s/Z > 4a = 3a > 2c > 7a/1c = 3b |
| Bangladesh, 2014 (n = 415) | 2a > 2b > 3a > 6 > 1b > 4a > 7a/1c > Y > 5b > 1a > 3b |
| Gems, 2014, 7 countries (n = 745) | 2a > 6 > 2b > 3a > 1b > 4a > 7a/1c > X > Y>1a = 5b > 3b |
| Bangladesh, 2018 (n = 3569) | 2a > 3a > 2b > 6>1b > 7a/1c > 4 s/Z > Y>1a > 3b = X > 4a = 5a > 4b > 5b |
Distribution of virulence genes among S. flexneri subtypes
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Type 2a | 100% (48/48) | 89.6% (43/48) | 89.6% (43/48) | 91.7% (44/48) | 91.7% (44/48) | 89.6% (43/48) | 93.7% (45/48) |
| Type 6 | 100% (15/15) | 80% (12/15) | 86.7% (13/15) | 20% (3/15) | 20% (3/15) | 93.3% (14/15) | 93.3% (14/15) |
| Type 1b | 100% (8/8) | 25% (2/8) | 50% (4/8) | 25% (2/8) | 25% (2/8) | 37.5% (3/8) | 87.5% (7/8) |
| Type 1 variant* (1v) | 100% (7/7) | 71.4% (5/7) | 71.4% (5/7) | 0 | 0 | 71.4% (5/7) | 85.7% (6/7) |
| Type 3b | 100% (12/12) | 83.3% (10/12) | 75% (9/12) | 33.3% (4/12) | 33.3% (4/12) | 83.3% (10/12) | 75% (9/12) |
| Type 4 | 100% (6/6) | 66.7% (4/6) | 66.7% (4/6) | 66.7% (4/6) | 66.7% (4/6) | 66.7% (6/6) | 66.7% (6/6) |
| Variant X | 100% (1/1) | 100% (1/1) | 100% (1/1) | 100% (1/1) | 100% (1/1) | 100% (1/1) | 100% (1/1) |
| Variant Y | 100% (2/2) | 100% (2/2) | 100% (2/2) | 0 | 0 | 50% (1/2) | 50% (1/2) |
| Nontypable | 100% (2/2) | 50% (1/2) | 50% (1/2) | 50% (1/2) | 50% (1/2) | 0 | 100% (2/2) |
| TOTAL | 100% (101/101) | 83.4% (84/101) | 81.2% (82/101) | 58.4% (59/101) | 58.4% (59/101) | 83.4% (84/101) | 91.1% (92/101) |
*Identified in this study only
List of primers used in the study
| Gene target | Primer sequence (5′-3′) | Gene location | Amplicon size in base pair (bp) | Reference |
|---|---|---|---|---|
|
| F:TGGAAAAACTCAGTGCCTCT | Plasmid and chromosome | 423 | [ |
| R:CCAGTCCGTAAATTCATTCT | ||||
|
| F:CTGGATGGTATGGTGAGG | Plasmid | 320 | [ |
| R:GGAGGCCAACAATTATTTCC | ||||
|
| F:TCACGCTACCATCAAAGA | SHI-1 pathogenicity island | 309 | [ |
| R:TATCCCCCTTTGGTGGTA | ||||
|
| F:GTGAACCTGCTGCCGATATC | SHI-1 pathogenicity island | 147 | [ |
| R:ATTTGTGGATAAAAATGACG | ||||
|
| F:ATGTGCCTGCTATTATTTAT | Plasmid | 799 | [ |
| R:CATAATAATAAGCGGTCGC | ||||
|
| F:CAATGACGGTTAGCTCAGGCA | Plasmid | 450 | This study |
| R: AAAGACGCCATCTCTTCTCGAT | ||||
|
| F:GCAGGCATTGCTGGGTAA | Plasmid | 1319 | [ |
| R:ACACTTGTAAGTTTTCAACTACG |